Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SAR442257 |
Synonyms | |
Therapy Description |
SAR442257 is a trispecific T cell engager that targets CD38, CD3 and CD28, which potentially results in enhanced T-cell dependent cytotoxicity of cancer cells (Cancer Res 2020;80(16 Suppl):Abstract nr 5641). |